NFX-179

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameNFX-179
Drug Alias NameNFX-179
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDual specificity mitogen-activated protein kinase kinase inhibitors
TargetsDual specificity mitogen-activated protein kinase kinase
Therapy Area/IndicationsNevus, Sebaceous of JadassohnNevusNeurofibromatosis 1 +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesNflection Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNflection Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeurofibromatosis 1Neurofibroma
Inactive IndicationsNevus, Sebaceous of JadassohnNevus

Other Information

ATC CodeN/A
Related LinksN/A